-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Mirae Asset Global Investments Co. Ltd. Has $1.30 Million Stock Position in InterCure Ltd. (NASDAQ:INCR)
Mirae Asset Global Investments Co. Ltd. Has $1.30 Million Stock Position in InterCure Ltd. (NASDAQ:INCR)
Mirae Asset Global Investments Co. Ltd. decreased its stake in InterCure Ltd. (NASDAQ:INCR – Get Rating) by 78.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 182,459 shares of the company's stock after selling 654,427 shares during the period. Mirae Asset Global Investments Co. Ltd. owned approximately 0.43% of InterCure worth $1,295,000 at the end of the most recent reporting period.
Separately, Davy Global Fund Management Ltd bought a new position in InterCure in the first quarter worth $152,000. Hedge funds and other institutional investors own 9.34% of the company's stock.
Get InterCure alerts:InterCure Stock Down 1.3 %
Shares of INCR stock opened at $5.30 on Friday. The stock has a market cap of $226.50 million and a P/E ratio of 29.44. InterCure Ltd. has a one year low of $5.18 and a one year high of $8.77. The stock has a fifty day moving average price of $5.93 and a 200 day moving average price of $6.33. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.87 and a quick ratio of 1.26.
About InterCure
(Get Rating)InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector.
See Also
- Get a free copy of the StockNews.com research report on InterCure (INCR)
- Why This Dip in Advanced Auto Parts May be an Opportunity
- MarketBeat: Week in Review 8/22 – 8/26
- Institutional Buying Put A Bottom In Marvell Technology
- Dell Stock Retreats On Weaker Sales, Falls Into Value Terrirtory
- 3 Reasons Dollar General's Rally Has Legs
Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InterCure Ltd. (NASDAQ:INCR – Get Rating).
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.
Mirae Asset Global Investments Co. Ltd. decreased its stake in InterCure Ltd. (NASDAQ:INCR – Get Rating) by 78.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 182,459 shares of the company's stock after selling 654,427 shares during the period. Mirae Asset Global Investments Co. Ltd. owned approximately 0.43% of InterCure worth $1,295,000 at the end of the most recent reporting period.
未來資產全球投資有限公司(Mirae Asset Global Investments Co.Ltd.)在提交給美國證券交易委員會的最新Form 13F文件中稱，該公司在第一季度減持了78.2%的InterCure Ltd.(納斯達克代碼：INCR-GET)。該基金在此期間出售了654,427股後，持有182,459股該公司股票。在最近的報告期結束時，未來資產全球投資有限公司擁有InterCure約0.43%的股份，價值1,295,000美元。
Separately, Davy Global Fund Management Ltd bought a new position in InterCure in the first quarter worth $152,000. Hedge funds and other institutional investors own 9.34% of the company's stock.
另外，Davy Global Fund Management Ltd在第一季度購買了InterCure的一個新頭寸，價值15.2萬美元。對衝基金和其他機構投資者持有該公司9.34%的股份。
InterCure Stock Down 1.3 %
InterCure股價下跌1.3%
Shares of INCR stock opened at $5.30 on Friday. The stock has a market cap of $226.50 million and a P/E ratio of 29.44. InterCure Ltd. has a one year low of $5.18 and a one year high of $8.77. The stock has a fifty day moving average price of $5.93 and a 200 day moving average price of $6.33. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.87 and a quick ratio of 1.26.
上週五，INCR的股票開盤報5.30美元。該股市值為2.265億美元，市盈率為29.44倍。InterCure Ltd.的股價一年來最低為5.18美元，一年來最高為8.77美元。該股的50日移動均價為5.93美元，200日移動均價為6.33美元。該公司的債務權益比為0.13，流動比率為1.87，速動比率為1.26。
About InterCure
關於InterCure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector.
InterCure有限公司及其子公司在以色列和國際上從事醫用大麻產品的研究、種植、生產、營銷和分銷。它提供乾燥的大麻花序和混合了油的大麻提取物。該公司還投資於BioMed部門。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on InterCure (INCR)
- Why This Dip in Advanced Auto Parts May be an Opportunity
- MarketBeat: Week in Review 8/22 – 8/26
- Institutional Buying Put A Bottom In Marvell Technology
- Dell Stock Retreats On Weaker Sales, Falls Into Value Terrirtory
- 3 Reasons Dollar General's Rally Has Legs
- 免費獲取StockNews.com關於InterCure的研究報告(INCR)
- 為什麼進軍高級汽車零部件可能是一個機會
- MarketBeat：回顧中的一週8/22-8/26
- 機構買入讓Marvell科技陷入低谷
- 戴爾股票因銷售疲軟而回落，跌入可怕的價值
- Dollar General的拉力賽有三個理由
Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InterCure Ltd. (NASDAQ:INCR – Get Rating).
想看看其他對衝基金持有什麼嗎？訪問HoldingsChannel.com獲取InterCure Ltd.(納斯達克：INR-GET評級)的最新13F備案文件和內幕交易信息。
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.
接受InterCure Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對InterCure和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧